Closed · RFA-CA-21-032 · CFDA 93.395;93.399 · Discretionary
Coordinating Center for Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium (U24 Clinical Trial Not Allowed)
Federal grant opportunity posted by National Institutes of Health, cataloged on Grants.gov.
- up to $875K
- Award range
- Closed
- Status
- July 14, 2021
- Close date
- 1
- Expected awards
The verdict
Coordinating Center for Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium (U24 Clinical Trial Not Allowed) is a closed discretionary listing from National Institutes of Health that offered Up to $875,000 across 1 expected award. Future funding cycles may be published under the same CFDA number.
- up to $875K
- award range
- Closed
- application status
- 1
- expected award
- 93.395;93.399
- CFDA program
Opportunity snapshot. This Grants.gov announcement - Coordinating Center for Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium (U24 Clinical Trial Not Allowed) - is cataloged under number RFA-CA-21-032 and tied to CFDA assistance listing 93.395;93.399, posted by National Institutes of Health. Grants.gov currently shows the opportunity as closed, first posted on May 3, 2021. The funding category is Discretionary, delivered as a cooperative agreement.
Award economics. The award range on file is Up to $875,000. The agency has projected $1.0 million in total estimated funding for this announcement. It expects to issue 1 award. If the agency funds the expected 1 award from the $1.0 million estimated pool, the average award works out to roughly $1.0 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.
Deadline and action path. This opportunity closed on July 14, 2021. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.
Award Range
Up to $875,000
Close Date
July 14, 2021
Posted
May 3, 2021
Est. Total Funding
$1,000,000
Expected Awards
1
Instrument
Cooperative Agreement
Description
Through this Funding Opportunity Announcement (FOA), the National Cancer Institute will support a Coordinating Center (CC) to facilitate coordination across the new Exercise and Medical nutrition Interventions to Improve Cancer Treatment-related Outcomes awardee sites (see U01 awards supported under companion RFA-CA-21-031). This CC will support three to five anticipated cooperative agreement (U01) project sites focused on the conduct of exercise and medical nutrition clinical trials to improve cancer treatment-related outcomes. The CCs primary mission will include collaborative scientific contribution and entail administrative and communication responsibilities. The activities and responsibilities include, but are not limited to, fostering collaboration among transdisciplinary scientific teams across U01 research sites, facilitating identification and collection of common data across U01 sites for use in pilot projects, participating in cross U01 site pilot projects, and leading data analyses, exploring opportunity for novel data collection, examining common research questions across U01 sites, and providing communication and logistical support for annual in-person meetings of the U01 project sites and other cross-site virtual meetings of U01 investigators. The CC will also develop and execute a platform to monitor progress facilitate the evaluation of the initiative across U01 project sites. The awardee will participate in an Exercise and Nutrition to Improve Cancer Treatment-related Outcomes (ENICTO) cooperative agreement consortium.
Eligibility
Grants.gov lists this opportunity under eligibility category codes 00, 01, 02, 04, 05, 06, 07, 08, 11, 12, 13, 20, 22, 23, 25. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
NIH OER Webmaster grantsinfo@nih.gov
Key Dates
Frequently Asked Questions
What is this grant opportunity?
Is this opportunity still open?
How much funding is available?
How do I apply?
More from National Institutes of Health
Validation Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U54 Clinical Trials Not Allowed)
Logistics Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U24 Clinical Trials Not Allowed)
Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)
PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional)
Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional)
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
Related
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |